Company / Operating Income per Share
Integra Lifesciences Holdings Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$6.14
FY2025
5-year range
-$6.14 / $2.80
FY2021-FY2025
Trend
-1905.3%
vs FY2024
Sector context
#149 of 154
Health Care
What the data says
Operating Income per Share changed -1905% YoY in FY2025, a notable deviation from the 9-year average annual change of -213%.
Based on SEC 10-K filings.
-6.14 in FY2025.
Declined from $1.30 to $-6.14 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 154This company -$6.14 Sector average $4.25
▼
-244.4% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's operating income per share has declined for 3 consecutive years.
- In FY2025, operating income per share decreased 1905.3% year-over-year.
- Ranks #149 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.14 | -1905.3% |
| FY2024 | $0.34 | -73.9% |
| FY2023 | $1.30 | -53.5% |
| FY2022 | $2.80 | +22.9% |
| FY2021 | $2.28 | +26.5% |
| FY2020 | $1.80 | +52.1% |
| FY2019 | $1.19 | -15.5% |
| FY2018 | $1.40 | +25.7% |
| FY2017 | $1.12 | +8.4% |
| FY2016 | $1.03 | -62.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026